sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ϵĤÔöÖ³ÐÔÉöСÇòÉöÑ×¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÃÚÄòϵͳģ×Ó > ϵĤÔöÖ³ÐÔÉöСÇòÉöÑ×¶¯ÎïÄ£×Ó

ǰÑÔ

ÉöСÇò¼²²¡(glomerular diseases)ÊDz¡Òò¡¢·¢²¡»úÖÆ¡¢ÁÙ´²ÌåÏÖ¡¢²¡Àí¸Ä±ä¡¢²¡³ÌºÍÔ¤ºó²»¾¡ÏàͬµÄÖ÷ÒªÀÛ¼°Ë«ÉöÉöСÇòµÄÒ»×é¼²²¡£¬¿É·ÖΪԭ·¢ÐÔ¡¢¼Ì·¢ÐÔºÍÒÅ´«ÐÔ¡£´ó¶¼ÉöСÇòÉöÑ×ÊÇÃâÒ߽鵼ÐÔÑ×Ö¢¼²²¡¡£Ò»Ñùƽ³£ÒÔΪ£¬ÃâÒß»úÖÆÊÇÉöСÇò²¡µÄʼ·¢»úÖÆ£¬ÉöСÇò¼²²¡¶¯ÎïÄ£×ÓÔÚ̽ÌÖ·¢²¡»úÖÆ¡¢²¡ÀíÀú³ÌÒÔ¼°ÁÙ´²ÖÎÁƵȷ½ÃæÊ©Õ¹Ö÷Òª×÷Óᣱ¾½ÚÖ÷ÒªÏÈÈÝÁËϵĤÔöÖ³ÐÔÉöСÇòÉöÑס¢Thy1ϵĤÔöÉúÐÔÉöÑס¢Ï¸Ð¡²¡±äÐÍÉö²¡¡¢IgAÉö²¡ÒÔ¼°ÉöСÇòÓ²»¯ÐÔÉö²¡¶¯ÎïÄ£×ӵĽ¨ÉèÒªÁìºÍÌØµã¡£

ϵĤÔöÖ³ÐÔÉöСÇòÉöÑ×(mesangial proliferative glomerulonephritis)ÊÇÆ¾Ö¤¹â¾µËù¼ûµÄÒ»ÖÖ²¡ÀíÐÎ̬ѧÕï¶ÏµÄÉöÑ×£¬ÊÇÒ»×éÒÔÃÖÂþÐÔÉöСÇòϵĤϸ°ûÔöÉú¼°²î±ðˮƽϵĤ»ùÖÊÔö¶àΪÖ÷ÒªÌØÕ÷µÄÉöСÇò¼²²¡¡£ÁÙ´²ÉÏÌåÏÖΪÒþÄäÐÔÉöСÇò¼²²¡¡¢ÂýÐÔÉöСÇòÑ×¼°Ô­·¢ÐÔÉö²¡×ÛºÏÕ÷¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

´ó³¦°£Ï£¾ú¡¢Å£ÑªÇåÇåÂѰ×(bovine serum albumin,BSA)¡¢ÆÏÌÑÇò¾ú³¦¶¾ËØB(staphylococcal enterotoxin B,SEB)¡¢ÖзÖ×Ó¿¹Ô­ÂÑÇåÂѰ׵ȿ¹Ô­ÍŽ᲻ÍêÈ«»òÍêÈ«¸¥ÊÏ×ô¼ÁÒýÆð賦ð¤Ä¤ÃâÒߣ¬µ¼Ö´ó×ÚµÄÃâÒ߸´ºÏÎï³Á»ý£¬´Ó¶øÓÕ·¢ÒÔÉöСÇòϵĤÔöÉúΪÖ÷Òª²¡Àí¸Ä±äµÄÉö²¡Ä£×Ó¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

1.ʵÑéÀú³Ì Ñ¡ÓÃ6ÖÜÁäÐÛÐÔSprague Dawley´óÊó£¨ÌåÖØ160~200g)£¬´ÓʵÑéµÄµÚ1ÌìÆðÒÔº¬20mgµÄBSAË®ÈÜÒº£¬¸ôÈÕ¹à裬¹²14ÖÜ¡£ÆäÖУ¬µÚ1ÌìÆ¤ÏÂ×¢ÉäÍêÈ«¸¥ÊÏ×ô¼Á0.2ml£¨º¬BSA 2mg),µÚ8Ì쾭ƤÏÂ×¢Éä²»ÍêÈ«¸¥ÊÏÊÔ¼Á0.2ml£¨º¬BSA 2mg)£¬Í¬Ê±¾²Âö×¢ÉäSEB(0.4mg/kg)£¬µÚ15ÌìÔÙ¾²Âö×¢ÉäSEB(0.4mg/kg)¡£

2.Ö¸±êÊÓ²ì »®·ÖÔÚµÚ10ÖÜ¡¢12ÖÜ¡¢14ÖܾÙÐÐÄòºìϸ°û¾µ¼ì¡¢ÄòÂѰ׼ì²âÒÔ¼°24СʱÄòÂѰ׶¨Á¿¡£ÊµÑéǰ¼°Õý·¨Ê±»®·Ö¼ì²âѪÇåÄòËØµª(blood urea nitrogen,BUN)¡¢¼¡ôû(creatinine,Cr)¡¢×ܵ¨¹Ì´¼¡¢×ÜÂѰ׼°Ñ­»·ÃâÒ߸´ºÏÎïˮƽ¡£Í¬Ê±¶ÔÉöÔಡÀíÇÐÆ¬¾ÙÐÐH&E¡¢PAS¡¢PASM¼°MassonȾɫ£¬¹â¾µÊÓ²ìÉöСÇòµÄ²¡Àíת±ä£¬²¢¾ÙÐÐÉöСÇòϵĤϸ°û¼ÆÊýºÍÉöСÇòϵĤÔöÉúˮƽÆÀ¼Û¡£Åжϱê×¼£ºÇá¶ÈΪϵĤÇá¶ÈÔöÉú£¬Ã«Ï¸Ñª¹ÜδÊÜѹ»òÇá¶ÈÊÜѹ£»ÖضÈÎªÏµÄ¤ÖØ¶ÈÔöÉú£¬ÒÔϵĤ»ùÖÊΪÖ÷£¬Ã«Ï¸Ñª¹ÜÑÏÖØÊÜѹ£»ÖжÈΪϵĤÔöÉúˮƽ½éÓÚÁ½ÕßÖ®¼ä¡£×îºóʹÓÃ͸Éäµç¾µÊÓ²ìÉöÔàµÄ³¬Î¢½á¹¹¡£

¡¾Ä£×ÓÌØµã¡¿£º

1.ʵÑé10ÖÜ´óÊó·ºÆðÂѰ×Äò£¬24СʱÄòÂѰ×Ëæ×Åʱ¼äµÄÑÓÉì¶øÔöÌí£¬°éÓÐѪÇåCrµÄÏÔ×ÅÉý¸ß¡£

2.ÉöϵĤ»ùÖÊÖжÈÔöÉú£¬ÉöСÇòϸ°ûÊýÇá¶ÈÔö¶à£¬ÉöС¹Ü¼äÖÊÎÞÏÔ×Åת±ä£¬ÉöСÇòÏµÄ¤ÇøÓдó×ÚIgAÓ«¹â³Á»ý¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ϵĤÔöÖ³ÐÔÉöÑ×ÊÇÈËÀàÔ­·¢ÐÔÉöСÇò¼²²¡×î³£¼ûµÄ²¡ÀíÀàÐÍ£¬Ô¼Õ¼Õû¸öÉöÔ༲²¡µÄ50%~60%¡£±¾Ä£×Ó×ÛºÏÓ¦ÓÃBSA¹àθ¡¢¸¥ÊÏ×ô¼ÁƤÏÂ×¢Éä¡¢SEB¾²Âö×¢É䣬½¨ÉèÁËÒ»ÖÖ²¡±äÎȹ̵ĴóÊóϵĤÔöÖ³ÐÍÉöСÇòÉöÑ×Ä£×Ó£¬¿ÉÓÃÓÚÑо¿ÏµÄ¤ÔöÖ³ÐÍÉöСÇòÉöÑ׵ķ¢²¡»úÖÆÒÔ¼°Î¸³¦µÀð¤Ä¤ÃâÒßÔÚ·¢²¡Àú³ÌÖеÄ×÷Óá£

 

²Î¿¼ÎÄÏ×£º

1.ÌÀÓ±£¬Â¦Ì½Ææ£¬³É²ÊÁª£¬µÈʵÑéÐÔIgAÉö²¡Ä£×ÓµÄˢУ®ÖÐɽ´óѧѧ±¨£¨Ò½Ñ§¿ÆÑ§°æ£©£¬2006,27 (2): 184-187

2.Î⺺Àû£¬Ëïΰ£®°¢Èá±ÈÐǽ¨ÉèÉö²¡Ä£×ӵįÀ¼Û£®ÖйúÖÐÒ½¼±Ö¢£¬2010,19 (2):290-191

3.ÕÅÀö·Ò£¬»ÆÎÄÕþ£¬ÖìС馣¬µÈ£®°¢Ã¹ËØÉö²¡ÉöСÇòÓ²»¯¶¯ÎïÄ£×ÓµÄÑо¿. ÖйúÖÐÎ÷ҽ͎áÉö²¡ÔÓÖ¾£¬2005,6 (4):195-199

4.Õſ˷Ç£¬ÕÅÁÁ£¬ÎâÐÛ·É£¬µÈ£®´óÊó¿¹Thy1ϵĤÔöÉúÐÔÉöСÇòÉöÑ×Ä£×Ó·¢²¡»úÖÆÌ½ÌÖ£®ËÄ´¨´óѧѧ±¨£¨Ò½Ñ§°æ£©£¬ 2004,35 (2): 188-190

5.³Â¹ãƽ£¬¹ù¹§ÒÀ£¬ÕÅԶ𣬵ȣ®´óÊóThy1¿¹ÑªÇåÖÆ±¸¼°ÏµÄ¤ÔöÉúÐÔÉöÑ×Ä£×ӵĽ¨É裮ÁÙ´²ÓëʵÑ鲡ÀíѧÔÓÖ¾£¬1996, 12 (3):241-243

6.»ÆÊ¤£¬ËïÁÖ£¬Ò¶Èθߣ¬µÈ£®Á½ÖÖϵĤÔöÖ³ÐÔÉöÑ×´óÊóÄ£×ӵĽ¨Éè½ÏÁ¿£®ÖйúʵÑ鶯Îïѧ±¨£¬2002, 10 (4): 236-238

7.Marquina R, Dfez MA,López-Hoyos M,el al. Inhibition of B cell death causes the development of an lgA nephropathy in(New Zealand white x C578L/6)F(l)-bel-2 transgenic mice. J lmmunol,2004,172(11):7177-7185

8.Zhang Z, Kundu GC, Yuan CJ, el al. Severe fibroneclin­deposit renal glomerular disease in mice lacking uteroglobin. Science, 1997,276(5317): 1408-1412

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÃÚÄòϵͳģ×Ó > ϵĤÔöÖ³ÐÔÉöСÇòÉöÑ×¶¯ÎïÄ£×Ó
ϵĤÔöÖ³ÐÔÉöСÇòÉöÑ×¶¯ÎïÄ£×Ó

ǰÑÔ

ÉöСÇò¼²²¡(glomerular diseases)ÊDz¡Òò¡¢·¢²¡»úÖÆ¡¢ÁÙ´²ÌåÏÖ¡¢²¡Àí¸Ä±ä¡¢²¡³ÌºÍÔ¤ºó²»¾¡ÏàͬµÄÖ÷ÒªÀÛ¼°Ë«ÉöÉöСÇòµÄÒ»×é¼²²¡£¬¿É·ÖΪԭ·¢ÐÔ¡¢¼Ì·¢ÐÔºÍÒÅ´«ÐÔ¡£´ó¶¼ÉöСÇòÉöÑ×ÊÇÃâÒ߽鵼ÐÔÑ×Ö¢¼²²¡¡£Ò»Ñùƽ³£ÒÔΪ£¬ÃâÒß»úÖÆÊÇÉöСÇò²¡µÄʼ·¢»úÖÆ£¬ÉöСÇò¼²²¡¶¯ÎïÄ£×ÓÔÚ̽ÌÖ·¢²¡»úÖÆ¡¢²¡ÀíÀú³ÌÒÔ¼°ÁÙ´²ÖÎÁƵȷ½ÃæÊ©Õ¹Ö÷Òª×÷Óᣱ¾½ÚÖ÷ÒªÏÈÈÝÁËϵĤÔöÖ³ÐÔÉöСÇòÉöÑס¢Thy1ϵĤÔöÉúÐÔÉöÑס¢Ï¸Ð¡²¡±äÐÍÉö²¡¡¢IgAÉö²¡ÒÔ¼°ÉöСÇòÓ²»¯ÐÔÉö²¡¶¯ÎïÄ£×ӵĽ¨ÉèÒªÁìºÍÌØµã¡£

ϵĤÔöÖ³ÐÔÉöСÇòÉöÑ×(mesangial proliferative glomerulonephritis)ÊÇÆ¾Ö¤¹â¾µËù¼ûµÄÒ»ÖÖ²¡ÀíÐÎ̬ѧÕï¶ÏµÄÉöÑ×£¬ÊÇÒ»×éÒÔÃÖÂþÐÔÉöСÇòϵĤϸ°ûÔöÉú¼°²î±ðˮƽϵĤ»ùÖÊÔö¶àΪÖ÷ÒªÌØÕ÷µÄÉöСÇò¼²²¡¡£ÁÙ´²ÉÏÌåÏÖΪÒþÄäÐÔÉöСÇò¼²²¡¡¢ÂýÐÔÉöСÇòÑ×¼°Ô­·¢ÐÔÉö²¡×ÛºÏÕ÷¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

´ó³¦°£Ï£¾ú¡¢Å£ÑªÇåÇåÂѰ×(bovine serum albumin,BSA)¡¢ÆÏÌÑÇò¾ú³¦¶¾ËØB(staphylococcal enterotoxin B,SEB)¡¢ÖзÖ×Ó¿¹Ô­ÂÑÇåÂѰ׵ȿ¹Ô­ÍŽ᲻ÍêÈ«»òÍêÈ«¸¥ÊÏ×ô¼ÁÒýÆð賦ð¤Ä¤ÃâÒߣ¬µ¼Ö´ó×ÚµÄÃâÒ߸´ºÏÎï³Á»ý£¬´Ó¶øÓÕ·¢ÒÔÉöСÇòϵĤÔöÉúΪÖ÷Òª²¡Àí¸Ä±äµÄÉö²¡Ä£×Ó¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

1.ʵÑéÀú³Ì Ñ¡ÓÃ6ÖÜÁäÐÛÐÔSprague Dawley´óÊó£¨ÌåÖØ160~200g)£¬´ÓʵÑéµÄµÚ1ÌìÆðÒÔº¬20mgµÄBSAË®ÈÜÒº£¬¸ôÈÕ¹à裬¹²14ÖÜ¡£ÆäÖУ¬µÚ1ÌìÆ¤ÏÂ×¢ÉäÍêÈ«¸¥ÊÏ×ô¼Á0.2ml£¨º¬BSA 2mg),µÚ8Ì쾭ƤÏÂ×¢Éä²»ÍêÈ«¸¥ÊÏÊÔ¼Á0.2ml£¨º¬BSA 2mg)£¬Í¬Ê±¾²Âö×¢ÉäSEB(0.4mg/kg)£¬µÚ15ÌìÔÙ¾²Âö×¢ÉäSEB(0.4mg/kg)¡£

2.Ö¸±êÊÓ²ì »®·ÖÔÚµÚ10ÖÜ¡¢12ÖÜ¡¢14ÖܾÙÐÐÄòºìϸ°û¾µ¼ì¡¢ÄòÂѰ׼ì²âÒÔ¼°24СʱÄòÂѰ׶¨Á¿¡£ÊµÑéǰ¼°Õý·¨Ê±»®·Ö¼ì²âѪÇåÄòËØµª(blood urea nitrogen,BUN)¡¢¼¡ôû(creatinine,Cr)¡¢×ܵ¨¹Ì´¼¡¢×ÜÂѰ׼°Ñ­»·ÃâÒ߸´ºÏÎïˮƽ¡£Í¬Ê±¶ÔÉöÔಡÀíÇÐÆ¬¾ÙÐÐH&E¡¢PAS¡¢PASM¼°MassonȾɫ£¬¹â¾µÊÓ²ìÉöСÇòµÄ²¡Àíת±ä£¬²¢¾ÙÐÐÉöСÇòϵĤϸ°û¼ÆÊýºÍÉöСÇòϵĤÔöÉúˮƽÆÀ¼Û¡£Åжϱê×¼£ºÇá¶ÈΪϵĤÇá¶ÈÔöÉú£¬Ã«Ï¸Ñª¹ÜδÊÜѹ»òÇá¶ÈÊÜѹ£»ÖضÈÎªÏµÄ¤ÖØ¶ÈÔöÉú£¬ÒÔϵĤ»ùÖÊΪÖ÷£¬Ã«Ï¸Ñª¹ÜÑÏÖØÊÜѹ£»ÖжÈΪϵĤÔöÉúˮƽ½éÓÚÁ½ÕßÖ®¼ä¡£×îºóʹÓÃ͸Éäµç¾µÊÓ²ìÉöÔàµÄ³¬Î¢½á¹¹¡£

¡¾Ä£×ÓÌØµã¡¿£º

1.ʵÑé10ÖÜ´óÊó·ºÆðÂѰ×Äò£¬24СʱÄòÂѰ×Ëæ×Åʱ¼äµÄÑÓÉì¶øÔöÌí£¬°éÓÐѪÇåCrµÄÏÔ×ÅÉý¸ß¡£

2.ÉöϵĤ»ùÖÊÖжÈÔöÉú£¬ÉöСÇòϸ°ûÊýÇá¶ÈÔö¶à£¬ÉöС¹Ü¼äÖÊÎÞÏÔ×Åת±ä£¬ÉöСÇòÏµÄ¤ÇøÓдó×ÚIgAÓ«¹â³Á»ý¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ϵĤÔöÖ³ÐÔÉöÑ×ÊÇÈËÀàÔ­·¢ÐÔÉöСÇò¼²²¡×î³£¼ûµÄ²¡ÀíÀàÐÍ£¬Ô¼Õ¼Õû¸öÉöÔ༲²¡µÄ50%~60%¡£±¾Ä£×Ó×ÛºÏÓ¦ÓÃBSA¹àθ¡¢¸¥ÊÏ×ô¼ÁƤÏÂ×¢Éä¡¢SEB¾²Âö×¢É䣬½¨ÉèÁËÒ»ÖÖ²¡±äÎȹ̵ĴóÊóϵĤÔöÖ³ÐÍÉöСÇòÉöÑ×Ä£×Ó£¬¿ÉÓÃÓÚÑо¿ÏµÄ¤ÔöÖ³ÐÍÉöСÇòÉöÑ׵ķ¢²¡»úÖÆÒÔ¼°Î¸³¦µÀð¤Ä¤ÃâÒßÔÚ·¢²¡Àú³ÌÖеÄ×÷Óá£

 

²Î¿¼ÎÄÏ×£º

1.ÌÀÓ±£¬Â¦Ì½Ææ£¬³É²ÊÁª£¬µÈʵÑéÐÔIgAÉö²¡Ä£×ÓµÄˢУ®ÖÐɽ´óѧѧ±¨£¨Ò½Ñ§¿ÆÑ§°æ£©£¬2006,27 (2): 184-187

2.Î⺺Àû£¬Ëïΰ£®°¢Èá±ÈÐǽ¨ÉèÉö²¡Ä£×ӵįÀ¼Û£®ÖйúÖÐÒ½¼±Ö¢£¬2010,19 (2):290-191

3.ÕÅÀö·Ò£¬»ÆÎÄÕþ£¬ÖìС馣¬µÈ£®°¢Ã¹ËØÉö²¡ÉöСÇòÓ²»¯¶¯ÎïÄ£×ÓµÄÑо¿. ÖйúÖÐÎ÷ҽ͎áÉö²¡ÔÓÖ¾£¬2005,6 (4):195-199

4.Õſ˷Ç£¬ÕÅÁÁ£¬ÎâÐÛ·É£¬µÈ£®´óÊó¿¹Thy1ϵĤÔöÉúÐÔÉöСÇòÉöÑ×Ä£×Ó·¢²¡»úÖÆÌ½ÌÖ£®ËÄ´¨´óѧѧ±¨£¨Ò½Ñ§°æ£©£¬ 2004,35 (2): 188-190

5.³Â¹ãƽ£¬¹ù¹§ÒÀ£¬ÕÅԶ𣬵ȣ®´óÊóThy1¿¹ÑªÇåÖÆ±¸¼°ÏµÄ¤ÔöÉúÐÔÉöÑ×Ä£×ӵĽ¨É裮ÁÙ´²ÓëʵÑ鲡ÀíѧÔÓÖ¾£¬1996, 12 (3):241-243

6.»ÆÊ¤£¬ËïÁÖ£¬Ò¶Èθߣ¬µÈ£®Á½ÖÖϵĤÔöÖ³ÐÔÉöÑ×´óÊóÄ£×ӵĽ¨Éè½ÏÁ¿£®ÖйúʵÑ鶯Îïѧ±¨£¬2002, 10 (4): 236-238

7.Marquina R, Dfez MA,López-Hoyos M,el al. Inhibition of B cell death causes the development of an lgA nephropathy in(New Zealand white x C578L/6)F(l)-bel-2 transgenic mice. J lmmunol,2004,172(11):7177-7185

8.Zhang Z, Kundu GC, Yuan CJ, el al. Severe fibroneclin­deposit renal glomerular disease in mice lacking uteroglobin. Science, 1997,276(5317): 1408-1412

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿